Ivabradinum supplements the clinical efficacy of percutaneous coronary intervention in patients with coronary heart disease with stable angina
The review is devoted to the role of ivabradinum in the procedure of percutaneous coronary intervention (PCI) in patients with ischemic heart disease with stable angina. It is reported that reperfusion of the myocardium with PCI, even in combination with modern drug therapy, does not have a complete...
Main Authors: | D. M Aronov, M. G Bubnova |
---|---|
Format: | Article |
Language: | English |
Published: |
Concilium Medicum
2017-06-01
|
Series: | КардиоСоматика |
Subjects: | |
Online Access: | https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45322/pdf |
Similar Items
-
THE ROLE OF PULSE REDUCTION THERAPY IN ADDITIONAL IMPROVEMENT OF CLINICAL EFFECTS OF MYOCARDIAL REVASCULARIZATION IN CORONARY HEART DISEASE STABLE ANGINA PATIENTS
by: D. M. Aronov, et al.
Published: (2018-06-01) -
PERCUTANEOUS INTERVENTION IN STABLE ANGINA: WHAT ISSUES DO WE SOLVE?
by: Yu. A. Karpov, et al.
Published: (2018-04-01) -
Effect of preinfarction angina on primary percutaneous coronary intervention outcomes
by: Hamid Reza Sanati, et al.
Published: (2018-01-01) -
Nicorandil in patients with acute coronary syndrome and stable angina undergoing percutaneous coronary intervention: literature review
by: Neda Partovi, et al.
Published: (2015-01-01) -
Nicorandil in patients with acute coronary syndrome and stable angina undergoing Percutaneous Coronary Intervention: literature review
by: Neda Partovi, et al.
Published: (2014-12-01)